LRG protein and ulcerative colitis remission
Part of Digestive system, Immune system & allergy clinical trials.
This study looks at a protein called LRG in your blood or tissue to see if it can tell if your ulcerative colitis is in remission (quiet or not active). This might help doctors better monitor and treat UC in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of ulcerative colitis (UC).
- No other strict requirements—most people with UC may be able to join.
- You'll need to have some tests or biopsies as part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures a blood protein called LRG and compares it to how active your inflammatory bowel disease (IBD) is during a planned scope procedure. The goal is to see if this blood test could help doctors assess disease activity more easily in the future.
This trial studies people with ulcerative colitis who are in a 'remission-recurrence' state, meaning their symptoms come and go. It aims to better understand this pattern and may help guide future treatments.
This study looks at gut barrier function in people with ulcerative colitis who are in remission. It uses a non-invasive liver test to check for subtle changes in the body.
This trial is testing a simple urine test that may show how active your ulcerative colitis is, using a substance called PGE-MUM. It could help doctors check your disease without needing a scope or other invasive tests.
This study tests an investigational drug called LIV001 for people with mild-to-moderate ulcerative colitis. It aims to see if the drug is safe and may help reduce inflammation in the colon.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
Hear when a new Ulcerative Colitis in Histologic Remission trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.